MedTrace Logo

Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes

NCT01206452 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-05-17

Study results available
· View outcomes & findings →

Summary

The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.

Conditions

Interventions

DRUG

Prednisone

60mg of oral prednisone 2 days before procedure, day of procedure, and 1 day after procedure

OTHER

Placebo

60mg placebo pill given 2 days before procedure, day of procedure, and 1 day after procedure

PROCEDURE

Ablation Procedure

Atrial Fibrillation (AF) ablation

Sponsors & Collaborators

  • Dhanunjaya Lakkireddy, MD, FACC

    lead OTHER

Principal Investigators

  • Dhanunjaya Lakkireddy, MD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206452 on ClinicalTrials.gov